Partially automated whole-genome sequencing reanalysis of previously undiagnosed pediatric patients can efficiently yield new diagnoses buff.ly/31mEqgc

How to Make Rational Decisions in the Face of Uncertainty buff.ly/2EqGY4k

The Genotype-Tissue Expression Project buff.ly/2Zu22xX

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension buff.ly/3bTU7z0

Will artificial intelligence revolutionise cancer therapeutics and care? - Cancerworld buff.ly/32ly1lC

Interpreting the impact of noncoding structural variation in neurodevelopmental disorders buff.ly/2GgzyRH

The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG) buff.ly/303CJUr

How to Manage a Hybrid Team buff.ly/3ljI4yo

These are the top 10 job skills of tomorrow – and how long it takes to learn them buff.ly/31uNYoX

I am very happy to announce that I am returning to France, to take the lead of the French #IA and #Genomics team based in Paris within the Computational Sciences R&D team of JNJInnovative Medicine

Meet with Johnson & Johnson Innovation in France buff.ly/2ZsBqNj

A guide to vaccinology: from basic principles to new developments buff.ly/2WEGJIb

Save the date! On 5 May, we’re hosting a virtual scientific & partnering event on state-of-the-art developments in translational sciences.🔬 Learn more and register now: jji.jnj/drug_discovery

Advances in Drug Discovery: From Human Genetic Signatures to Drug Targets buff.ly/2ObOxk8

Meet with Johnson & Johnson Innovation in France buff.ly/39xHn17

L'engagement de Janssen France dans l'IA et la génomique buff.ly/3vUxnHX

L'engagement de Janssen France dans l'IA et la génomique #intelligenceartificielle #genomique #openinnovation #publicprivatepartnerships linkedin.com/posts/ramzitem…

Janssen’s goal is to harness the convergence of AI, machine learning and genomic data with traditional R&D to understand disease biology and discover new therapies for patients. Read more here: jji.jnj/3uz1lB1 JNJInnovative Medicine @JanssenFRA Institut Pasteur, since 1887 Assistance Publique – Hôpitaux de Paris (AP-HP)

Ethics and governance of artificial intelligence for health buff.ly/2Tfmv9U

🗓️ In less than a month, we will be hosting a virtual event with JNJInnovative Medicine on the next wave of immune cell engagers in hematological malignancies. Register now: jji.jnj/366BvK8